Michael A. Dorato, PhD, DABT, Fellow ATS

Dr. Dorato has over 35 years of experience, as a researcher and global leader of safety and efficacy in the pharmaceutical and CRO industries. Prior to joining Smithers, he was the Vice-President and CSO, Global Discovery Services (Covance) and Executive Director, Toxicology (Eli Lilly and Co.). In these positions he led global organizations in safety and efficacy lead optimization, investigative and regulatory toxicology, discovery and late phase pathology, animal welfare, molecular and anatomical imaging, in vivo pharmacology, veterinary medicine and model development. Dr. Dorato has more than 100 scientific publications/presentations.

Required fields *
*
*
*
Country *
*
*